Strategic Capital Advisers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $283K | Buy |
1,846
+6
| +0.3% | +$920 | 0.23% | 51 |
|
|
2022
Q1 | $298K | Buy |
1,840
+6
| +0.3% | +$972 | 0.23% | 50 |
|
|
2021
Q4 | $248K | Buy |
+1,834
| New | +$248K | 0.18% | 53 |
|
|
2020
Q2 | – | Sell |
-2,959
| Closed | -$225K | – | 50 |
|
|
2020
Q1 | $225K | Buy |
2,959
+130
| +5% | +$9.89K | 0.27% | 47 |
|
|
2019
Q4 | $250K | Buy |
2,829
+28
| +1% | +$2.47K | 0.23% | 57 |
|
|
2019
Q3 | $212K | Buy |
2,801
+15
| +0.5% | +$1.14K | 0.24% | 55 |
|
|
2019
Q2 | $203K | Buy |
2,786
+30
| +1% | +$2.19K | 0.21% | 55 |
|
|
2019
Q1 | $222K | Buy |
2,756
+530
| +24% | +$42.7K | 0.24% | 52 |
|
|
2018
Q4 | $205K | Buy |
2,226
+24
| +1% | +$2.21K | 0.22% | 51 |
|
|
2018
Q3 | $208K | Buy |
2,202
+21
| +1% | +$1.98K | 0.15% | 57 |
|
|
2018
Q2 | $212K | Buy |
2,181
+33
| +2% | +$3.21K | 0.16% | 57 |
|
|
2018
Q1 | $208K | Hold |
2,148
| – | – | 0.21% | 58 |
|
|
2017
Q4 | $208K | Buy |
+2,148
| New | +$208K | 0.2% | 59 |
|